Determination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis

Analytical Biochemistry

Volumn 389, Issue 1, 2009, Pages 74-76

  Leandro García, Luis J ^a   Leskelä, Susanna ^a   Montero Conde, Cristina ^a   Landa, Iñigo ^a   López Jimenez, Elena ^a   Letón, Rocío ^a   Seeringer, Angela ^b   Kirchheiner, Julia ^b   Cascón, Alberto ^a,c   Robledo, Mercedes ^a,c   Rodríguez Antona, Cristina ^a,c  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF ULM   (Germany)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; POLYMORPHISM;

ANALYSIS METHOD; CLINICAL DRUGS; CLINICAL SAMPLES; COPY NUMBER VARIATIONS; CYTOCHROME P450; GENE COPY NUMBER; RESTRICTION FRAGMENT LENGTH POLYMORPHISMS; SINGLE NUCLEOTIDE POLYMORPHISMS;

POLYMERASE CHAIN REACTION;

CYTOCHROME P450 2D6;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; GENE AMPLIFICATION; GENE NUMBER; HUMAN; MULTIPLEX POLYMERASE CHAIN REACTION; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

EID: 65049089917     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.03.021     Document Type: Article

References (21)

1. Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev. 34 (2002) 83-448
2. Zanger U.M., Fischer J., Raimundo S., Stuven T., Evert B.O., Schwab M., and Eichelbaum M. Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics 11 (2001) 573-585
3. Bernard S., Neville K.A., Nguyen A.T., and Flockhart D.A. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist 11 (2006) 126-135
4. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects, and functional diversity. Pharmacogenomics J. 5 (2005) 6-13
5. Kirchheiner J., Nickchen K., Bauer M., Wong M.L., Licinio J., Roots I., and Brockmoller J. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol. Psychiatry 9 (2004) 442-473
6. Zanger U.M., Raimundo S., and Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedeberg Arch. Pharmacol. 369 (2004) 23-37
7. Johansson I., Lundqvist E., Bertilsson L., Dahl M.L., Sjoqvist F., and Ingelman-Sundberg M. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc. Natl. Acad. Sci. USA 90 (1993) 11825-11829
8. Stuven T., Griese E.U., Kroemer H.K., Eichelbaum M., and Zanger U.M. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction. Pharmacogenetics 6 (1996) 417-421
9. Bodin L., Beaune P.H., and Loriot M.A. Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR. J. Biomed. Biotechnol. (2005) 248-253
10. Schaeffeler E., Schwab M., Eichelbaum M., and Zanger U.M. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum. Mutat. 22 (2003) 476-485
11. Stamer U.M., Bayerer B., Wolf S., Hoeft A., and Stuber F. Rapid and reliable method for cytochrome P450 2D6 genotyping. Clin. Chem. 48 (2002) 1412-1417
12. Soderback E., Zackrisson A.L., Lindblom B., and Alderborn A. Determination of CYP2D6 gene copy number by pyrosequencing. Clin. Chem. 51 (2005) 522-531
13. de Leon J., Susce M.T., and Murray-Carmichael E. The AmpliChip CYP450 genotyping test: integrating a new clinical tool. Mol. Diagn. Ther. 10 (2006) 135-151
14. Sachse C., Brockmoller J., Bauer S., and Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am. J. Hum. Genet. 60 (1997) 284-295
15. McWhinney S.R., Pilarski R.T., Forrester S.R., Schneider M.C., Sarquis M.M., Dias E.P., and Eng C. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J. Clin. Endocrinol. Metab. 89 (2004) 5694-5699
16. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., and Hurles M.E. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
17. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., and Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30 (2002) e57
18. Bradford L.D. CYP2D6 allele frequency in European Caucasians, Asians, Africans, and their descendants. Pharmacogenomics 3 (2002) 229-243
19. Johansson I., Lundqvist E., Dahl M.L., and Ingelman-Sundberg M. PCR-based genotyping for duplicated and deleted CYP2D6 genes. Pharmacogenetics 6 (1996) 351-355
20. Sistonen J., Sajantila A., Lao O., Corander J., Barbujani G., and Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet. Genomics 17 (2007) 93-101
21. Meijerman I., Sanderson L.M., Smits P.H., Beijnen J.H., and Schellens J.H. Pharmacogenetic screening of the gene deletion and duplications of CYP2D6. Drug Metab. Rev. 39 (2007) 45-60